Professor Pinar Ayata, CUNY ASRC Neuroscience Initiative, and colleagues identify a key cellular mechanism driving alzheimer’s disease. Their findings mark a promising target for drug therapies that slow, possibly reverse, the disease’s development.
bit.ly/4iNfynn
ALT Electron micrographs show typical microglia in the prefrontal cortex of a 92-year-old healthy female (left) and dark microglia a 91-year-old female patient with Alzheimer’s disease (right).